Titrating too quickly increases the likelihood of nausea, fatigue, and other side effects
Keith Ladner is a double board-certified and fellowship-trained facial plastic surgeon in Denver, CO and Beverly Hills, CA
Starting GLP-1 injections can feel a bit intimidating at first, but with the right know-how, it becomes a smooth part of your routine
MAFLD: metabolic associated fatty liver disease
Severe insulin deficiency represents a significant limitationpatients with longstanding type 2 diabetes who have substantial beta-cell dysfunction may not respond adequately to GLP-1 receptor agonists alone, as these medications work by enhancing glucose-dependent insulin secretion
Incretin therapies The first generation of weight-loss medications are incretin therapies that regulate insulin secretion, building on type 2 diabetes mellitus (T2DM) treatments utilising glucagon-like peptide-1 (GLP-1) receptor agonists